# Alphageneron Pharmaceuticals, Inc. — Form D

Alphageneron Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-14. The offering totals $250K, of which $250K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2023-08-14
- Form: D
- Accession: 0001812191-23-000005
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $250K
- Amount sold: $250K
- Investors: 1
- Date of first sale: 2023-06-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-489584

## Issuer

- Name: Alphageneron Pharmaceuticals, Inc.
- CIK: 0001812191
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1441 BROADWAY, 3RD FLOOR, NEW YORK, NY, 10018
- Phone: 6465695522

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Robert Brooks | Director | Kansas City, MO |
| Robert Clarke | Director | Dover, DE |
| Marc Lippman | Director | Boston, MA |
| Bikash Verma | Director | New York, NY |
| Robert Brooks | Executive Officer | Kansas City, MO |
| Graham Pockley | Executive Officer | New York, NY |
| Ola Soderquist | Executive Officer | New York, NY |

## More

- [CIK 1812191 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1812191&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001812191-23-000005.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.